Covetrus Celebrates Delivery of its 2,000th Puppy Care Package in Support of Canine Companions for Independence

Employee-led Philanthropic Initiative Supports the Development and
Training of Service Dogs that Help People with Disabilities Increase
Independence

PORTLAND, Maine–(BUSINESS WIRE)–Covetrus (NASDAQ: CVET), a global animal-health technology and services
company supporting the companion, equine, and large-animal veterinary
markets, today announced that its multi-year support of Canine
Companions for Independence® has reached a momentous
milestone with the delivery of its 2,000th Puppy Care Package.

Since 2015, Covetrus employees have supported Canine
Companions for Independence
, a non-profit organization that enhances
the lives of people with disabilities by providing highly trained
assistance dogs at no charge to the recipient. These past four years,
Covetrus in partnership with veterinarians has provided Canine
Companions volunteer puppy raisers with a Puppy Care Package stocked
with products essential to raising the puppy during the first 18 months
of life.

We are thrilled to have delivered our 2,000th Puppy Care
Package in support of Canine Companions for Independence,” said Davey
Stone, vice president, specialty markets and corporate philanthropy,
Covetrus. “This philanthropic initiative was designed and managed by
Covetrus employees wanting to support volunteers who raise puppies for
Canine Companions and the veterinarians who provide their care. It has
been a rewarding mission for our employees, and a wonderful channel for
their compassionate philanthropic spirit.”

The 2,000th box was delivered to Dr. Lee Kaplow of Lakeside
Pet Hospital
in Folsom, CA, which in turn granted it to volunteer
puppy raiser Kim Brewer who is raising Fig, a Labrador Retriever. A
Puppy Care Package includes $350.00 worth of products sourced from
Covetrus and animal health manufacturers like Boehringer-Ingelheim, Kong
Veterinary Products, Midmark Corporation, Nutramax and Virbac Animal
Health.” Covetrus employees have supported this mission through
consistent fundraising and in turn, the company has matched employee
contributions and provided items for the boxes at a savings. In
addition, employees take care of all the logistics associated with the
Puppy Care Package—from the packing to the shipment—of these boxes to
veterinarians.

We’re grateful to Covetrus and their partners for providing the puppy
care packages,” said Brenda Kennedy, national director of canine health
and research at Canine Companions. “Our volunteer puppy raisers use the
donated preventatives, supplements and supplies to ensure that each
Canine Companion puppy gets a healthy start on their journey to becoming
an assistance dog.”

Puppy raisers are responsible for socializing and training the puppies.
The first 18 months is critical to training of future assistance dogs.
In that time-span the puppy must learn 25 commands that enable them to
assist their future partners, including opening doors, retrieving items,
or pulling a wheelchair. After 18 months the puppies progress on to
professional training for an additional four to six months. Upon
graduation they are reunited with their puppy raiser and presented to
their life-long partner.

About Covetrus
Covetrus is a global animal-health technology
and services company dedicated to empowering veterinary practice
partners to drive improved health and financial outcomes. We’re bringing
together products, services, and technology into a single platform that
connects our customers to the solutions and insights they need to work
best. Our passion for the well-being of animals and those who care for
them drives us to advance the world of veterinary medicine. Covetrus is
headquartered in Portland, Maine, with more than 5,000 employees,
serving over 100,000 customers around the globe. For more information
about Covetrus visit https://www.covetrus.com/.

Forward-Looking Statements
This press release contains
certain statements that are forward-looking within the meaning of
Section 27A of the Securities Act of 1933, as amended, and Section 21E
of the Securities Exchange Act of 1934, as amended, and that involve
risks and uncertainties, including statements about our future financial
and operating results, plans, objectives, expenses, expectations,
intentions, trends in our business, our liquidity, product development
and improvements, and other matters. We may, in some cases use terms
such as “predicts,” “believes,” “potential,” “continue,” “anticipates,”
“estimates,” “expects,” “plans,” “intends,” “may,” “could,” “might,”
“likely,” “will,” “should” or other words that convey uncertainty of the
future events or outcomes to identify these forward-looking statements.
Such statements are subject to numerous risks and uncertainties,
including but not limited to, risks associated with the ability to
successfully integrate operations and employees; the ability to realize
anticipated benefits and synergies of the transaction that
created Covetrus; the potential impact of the consummation of the
transaction on relationships, including with employees, customers and
competitors; the ability to retain key personnel; the ability to achieve
performance targets; changes in financial markets, interest rates and
foreign currency exchange rates, and those additional risks and factors
discussed in our Annual Report on Form 10-K filed on March 29, 2019 and
Quarterly Report on Form 10-Q filed for the quarter ended March 31,
2019, including those discussed under the heading “Risk Factors.” Our
forward-looking statements are based on current beliefs and expectations
of our management team and, except as required by law, we undertake no
obligations to make any revisions to the forward-looking statements
contained in this release or to update them to reflect events or
circumstances occurring after the date of this release, whether as a
result of new information, future developments or otherwise. Investors
are cautioned not to place undue reliance on these forward-looking
statements.

Contacts

Nicholas Jansen
Investor Relations
[email protected]
(207)
550-8106

Kiní Schoop
Public Relations
[email protected]
(207)
550-8018

error: Content is protected !!